{"id":610146,"date":"2026-07-29T15:20:14","date_gmt":"2026-07-29T15:20:14","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/610146\/"},"modified":"2026-07-29T15:20:14","modified_gmt":"2026-07-29T15:20:14","slug":"super-weight-loss-drug-retatrutide-could-be-available-soon","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/610146\/","title":{"rendered":"‘Super weight loss’ drug retatrutide could be available soon"},"content":{"rendered":"

KENT COUNTY, Mich \u2014 A new weight loss drug could soon be joining the growing list of medications helping Americans get healthy \u2014 and a West Michigan doctor says it may be the most powerful one yet.<\/p>\n

Retatrutide is being called a “super weight loss drug” by Dr. Celia Egan of True Women’s Health<\/a>, who says it outperforms existing options on the market.<\/p>\n

\"dr.<\/p>\n

FOX 17<\/p>\n

“Essentially, is a super weight loss drug. It’s much more potent than tirzepatide or semaglutide is,” Egan said. “What makes it special is it’s actually what they call a triple agonist, so that means it mimics three different GI tract hormones.”<\/p>\n

That potency is showing up in clinical results.<\/p>\n

“Now we’re talking about close to 28 to 30% body weight loss in some of these studies with retatrutide,” Egan said.<\/p>\n

\"Young,Woman,Measuring,Her,Weight,At,Home\"<\/p>\n

Pixel-Shot\/Shutterstock.com<\/p>\n

Young woman measuring her weight at home<\/p>\n

The drug won’t be for everyone, Egan says. She says the biggest benefits will be for patients who need to lose a significant amount of weight \u2014 between 50 and 100 pounds \u2014 as well as those with Type 2 diabetes and patients with fatty liver disease.<\/p>\n

The broader landscape of weight loss medications has already been shifting. From GLP-1s like Wegovy to Zepbound, more Americans than ever are turning to medication-assisted options.<\/p>\n

“I think the numbers continue to go up, just because patients are feeling more confident using these drugs, and the indications keep expanding,” Egan said.<\/p>\n

Egan says that trend is only going to continue.<\/p>\n

This month, Eli Lilly announced plans to seek FDA approval for retatrutide early next year.<\/a> Side effects, like stomach upset, are similar to those of other weight loss drugs. There is no word yet on cost.<\/p>\n

This story was reported on-air by a journalist and has been converted to this platform with the assistance of AI. Our editorial team verifies all reporting on all platforms for fairness and accuracy.<\/p>\n

Follow FOX 17:<\/b> Facebook<\/a> – X (formerly Twitter)<\/a> – Instagram<\/a> – YouTube<\/a><\/p>\n